Sheryl Stevenson

Matthew R. Starr, MD, discusses how secondary lens techniques have changed over time.

Richard B Rosen, MD, who is presenting New 'MacGyver-Inspired' Endolaser Option for Chandelier-Assisted Scleral Buckles at the 2023 ASRS meeting in Seattle, Washington spoke with our team about this research.

Cindy Cai, MD, who is presenting Health disparities in lapses in diabetic retinopathy care at the 2023 ASRS meeting in Seattle, Washington spoke with our team about this presentation.

Cochair Peter J. McDonnell, MD, highlights what this year’s conference will mean for clinicians and addresses the anticipated increased patient volume.

William B. Trattler, MD, highlights some of the novel therapies for dry eye that have recently been approved by the FDA, along with various treatment approaches that are in development.

Jeff Wongs, MD, discussed his study to assess the benefits of cryopreserved amniotic membrane prior to cataract surgery to restore the ocular surface and improve the accuracy of pre-op biometric readings

Jason Bacharach, MD, and Chris Pearson discussed the Preservative Freedom coalition from Théa Pharmaceutical at the 2023 ASCRS annual meeting in San Diego.

Lori Pacheco, RN, CRNO, discussed sports-related eye injuries and how to prevent them at the 2023 ASCRS annual meeting in San Diego.

Patrick Spencer, DO, discussed the safety and effectiveness comparison of hydrogel-based intracanalicular dexamethasone insert placement in the lower versus the upper punctum at the 2023 ASCRS annual meeting in San Diego.

John Hovanesian, MD, discussed his paper on the Apthera small aperture implant for patients with low degrees of astigmatism at the 2023 ASCRS annual meeting in San Diego.

Mahmoud Khaimi, MD, briefly discussed the launch of the iTrack Advance handheld device at the 2023 ASCRS annual meeting in San Diego.

Lisa Nijm, MD, discussed Preservative Freedom, a coalition that has been put together by Thea to help bring attention and bring awareness to creating preservative-free drops for all patients at the 2023 ASCRS annual meeting in San Diego.

Mitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.

Sam Garg, MD, discussed his paper on the 36-month outcomes for the Juvene modular intraocular lens at the 2023 ASCRS annual meeting in San Diego.

Warren Foust, chief operating officer of STAAR Surgical, discussed the company and looked toward the future at the 2023 ASCRS annual meeting in San Diego.

Brian Shafer, MD, discussed Fortisite and the ability to treat corneal ulcers at the 2023 ASCRS annual meeting in San Diego.

John Berdahl, MD, discussed the Aurion clinical trials of endothelial cell therapy injection at the 2023 ASCRS annual meeting in San Diego.

Daniel Chang, MD, discussed his paper on a study comparing TECNIS Symfony OptiBlue IOL with the TECNIS Symfony Legacy IOL at the 2023 ASCRS annual meeting in San Diego.

Robert Lin, MD, founder of IQ Laser Vision, discussed the new CellChek 20 at the 2023 ASCRS annual meeting in San Diego.

Rob Thornhill, CEO of Centricity Vision, discussed the FDA clearing of ZeptoLink at the 2023 ASCRS annual meeting in San Diego.

Anthony Wallace, Vice President and General Manager of the US Surgical Business at Bausch + Lomb, discussed the introduction of SeeLuma, a fully digital surgical visualization platform, and more at the 2023 ASCRS annual meeting in San Diego.

Patrick Herde, General Manager of Ophthalmology and Optometry at ModMed, discussed a retrospective on the company's 10-year anniversary 2023 ASCRS annual meeting in San Diego.

Denise M. Visco, MD, discussed her presentation on astigmatism management with a dual-pulse femtosecond laser called ALLY, from Lensar, at the 2023 ASCRS annual meeting in San Diego.

Edward Hu, MD, PhD, discussed his paper on the single surgeon retrospective comparative analysis of 517 eyes of two subgroups of routine cataract surgery at the 2023 ASCRS annual meeting in San Diego.

Zeba Syed, MD, from Wills Eye Hospital discussed their research on corneal swelling and dynamics during corneal collagen crosslinking at the 2023 ASCRS annual meeting in San Diego.

Sandor Palfi, Commercial Vice President of the Americas at Johnson & Johnson Vision discussed pipeline updates for the company including the ELITA femtosecond platform at the 2023 ASCRS annual meeting in San Diego.

Lowe is the VP, of Commercial Operations at Eyenovia, and discussed the FDA approval of MydCombi for mydriasis at the 2023 ASCRS annual meeting in San Diego.

Rob Weinstock, MD from the Eye Institute of West Florida presented on his experience working with the ALLY cataract femtosecond laser cataract system from LENSAR at the 2023 ASCRS annual meeting in San Diego.

Ophthalmology Times© met with Eva Liang at the 2023 ASCRS annual meeting in San Diego where she presented data on outcomes of the Rasch-scaled Catquest-9SF questionnaire before and after implantation of the enVista toric lens.